9:55am ET
Health and Healthcare
Why Bristol-Myers Squibb Could Be the Best Large-Cap Pharmaceutical Stock for 2020
Independent research firm Argus sees better than 25% potential upside for Bristol-Myers Squibb in the coming year.
Companies
Celgene
$108.24
â–² $0.00 (+0.00%) today
Markets closed · 7:15am ET
Today · % change
CELG Coverage
10:00am ET
Health and Healthcare
Major Biotechs See Rising Tide in Short Interest
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The October 31 short interest data has been compared with the previous report, and short interest in most…
10:05am ET
Health and Healthcare
Major Biotechs See Rising Tide in Short Interest
The October 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
10:00am ET
Health and Healthcare
Short Sellers Hike Bets in Major Biotechs
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The September 30 short interest data has been compared with the previous report, and short interest in most…
9:30am ET
Health and Healthcare
Major Biotechs Scare Off Short Sellers
The September 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
8:40am ET
Health and Healthcare
Major Biotechs Scare Off Short Sellers
The August 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
11:20am ET
Investing
7 Giant Mergers Transforming the Face of Corporate America
Many mergers have been announced or have closed, but just seven recent and pending deals have transformed how analysts and investors alike are having to view corporate America.
9:15am ET
Health and Healthcare
Short Sellers Hike Their Bets in Biotech
The August 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
3:20pm ET
Health and Healthcare
Is Amgen Overpaying for Celgene’s Psoriasis Treatment?
Both Amgen and Celgene shares made a handy gain on Monday after it was announced that the companies had made an agreement in relation to Celgene’s merger with Bristol-Myers Squibb.
12:10pm ET
Health and Healthcare
Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead
24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current prices.
8:50am ET
Health and Healthcare
Short Sellers Make a Move on Big Biotechs
The July 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
8:40am ET
Health and Healthcare
Major Biotechs See Rising Tide in Short Interest
The July 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
10:20am ET
Health and Healthcare
Why Jounce Therapeutics Popped
Jounce Therapeutics shares jumped on Wednesday after the company announced an update on its strategic collaboration with Celgene. This collaboration was originally established in July of 2016.
Chris Lange 9:50am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 28 short interest data has been compared with the previous report, and short interest in most…
10:05am ET
Health and Healthcare
Big Biotechs Scare Off Short Sellers
The June 14 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.